Common Pain Med Ingredient May Treat Blood Cancers
“`html
Salicylic Acid, Common in Skincare, Could Treat Blood Cancers
Salicylic acid, a commonly used skincare and pain medication ingredient, could now also be used to treat blood cancers, according to new research.
Two millennia after Hippocrates used willow bark to ease pain and fever, researchers at the Texas A&M University Health Science Center (Texas A&M Health) have transformed its key ingredient-salicylic acid-into a molecular “remote control” that can turn therapeutic cell functions on or off.
In the new study, Yubin Zhou and Yun Huang with the Texas A&M Health Institute of Biosciences and Technology used this technology-called Salicylic Acid-Mediated Binary Association (SAMBA)-to combat two common blood cancers: acute lymphoblastic leukemia and B cell lymphoma. Blood cancers account for approximately 10% of new cancer diagnoses each year.
SAMBA uses salicylic acid, or aspirin, which is a cost-efficient and widely available drug for therapeutic use, making it a promising alternative to more complex or expensive forms of cancer immunotherapy.
Immunotherapy-which uses the body’s own immune system to seek out and kill cancer cells-has been used as 1891 for bone cancer. But innovations like SAMBA are helping researchers make it safer and more effective.
SAMBA technology works by engineering CAR T cells so their cancer-killing activity can be turned on or off simply by giving or withholding salicylic acid, allowing doctors to precisely control when the treatment is active. In laboratory studies, SAMBA-equipped CAR T cells only destroyed cancer cells when salicylic acid was present. Stopping the salicylic acid “switch” caused the immune cells to pause their attack, offering a new safety layer over traditional CAR T cell therapy.
“Much like playing with a transformer toy,where you can quickly flip between a car and a robot,we’re trying to recreate that quick switch so we can better…
